Cumberland Pharmaceuticals (CPIX) Assets Average (2011 - 2026)

Cumberland Pharmaceuticals has disclosed Assets Average across 16 years of filings, most recently posting $66.9 million for Q2 2026.

• In Q2 2026, Assets Average fell 2.88% year-over-year to $66.9 million; the TTM figure through Jun 2026 stood at $66.9 million (down 2.88% YoY), while the FY2025 annual figure was $76.2 million, down 3.15% from the prior year.
• Assets Average came in at $66.9 million for Q2 2026 at Cumberland Pharmaceuticals, down from $73.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.6 million in Q2 2022 to a low of $66.9 million in Q3 2025.
• Average Assets Average over 5 years is $81.0 million, with a median of $80.8 million recorded in 2024.
• Year-over-year, Assets Average grew 6.78% in 2022 and dropped 13.86% in 2025.
• Over 5 years, Assets Average stood at $91.9 million in 2022, then decreased by 7.72% to $84.8 million in 2023, then declined by 10.14% to $76.2 million in 2024, then decreased by 6.31% to $71.4 million in 2025, then decreased by 6.2% to $66.9 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $66.9 million in Q2 2026, $73.9 million in Q1 2026, and $71.4 million in Q4 2025.